Details
Category: Volume 06 Issue 04 April 2018
Hits: 1352

Title: Antibiotic Susceptibility Pattern of Bacteria Isolated from Adult Patients with Ventilator Associated Pneumonia (VAP) in Intensive Care Units in a Tertiary Care Hospital

Authors: Anuradha De, Arghadip Samaddar, Salma Patwegar, Sujata Baveja

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i4.181

Abstract

Ventilator-associated pneumonia (VAP) refers to pneumonia developing in a patient on mechanical ventilator >48 hours after intubation or tracheostomy. VAP is an important cause of morbidity and mortality in mechanically ventilated patients. The aim of the study was to assess the clinical and bacteriological profile of VAP, risk factors, prevalence of multidrug-resistant pathogens in VAP cases in ICU setting and to correlate Endotracheal aspirate (ETA) with blood culture in those cases. The study included 130 adult patients of both sexes who were admitted to ICUs and fulfilling the criteria of VAP. Endotracheal aspirates (ETA) and blood samples were collected from the suspected VAP cases and subjected to culture and antimicrobial susceptibility testing as per standard protocol. Incidence of VAP was found to be 40.8%, out of which 81.13% had late-onset VAP. Diabetes mellitus, advancing age (>60 years) and Chronic Obstructive Pulmonary Disease were the important risk factors associated with VAP. The most frequently isolated microorganism was Acinetobacter species (70.37%), followed by Pseudomonas aeruginosa (14.81%) and Klebsiella pneumoniae (5.56%). All Acinetobacter species and 75% of Pseudomonas aeruginosa isolates were multidrug resistant. Overall carbapenem resistance was 46%. Blood culture results were positive for 47.16% cases of VAP of which 76% showed bacteraemia of pulmonary origin. Acinetobacter species (33.96%) was the most common isolate from blood. Mortality in VAP cases was 50.94%. Due to the increasing incidence of multidrug-resistant organisms in ICUs, early and correct diagnosis of VAP is an urgent challenge for an optimal antibiotic treatment and cure. Hence, knowledge of the local microbial flora causing VAP and effective infection control practices are essential to improve clinical outcome.

Keywords: Ventilator-associated pneumonia, Endotracheal aspirate, Acinetobacter species, Multidrug resistant

References

  1. Morehead RS, Pinto SJ. Ventilator-associated pneumonia. Arch Intern Med 2000;160(13):1926-36.
  2. Dey A, Bairy I. Incidence of multidrug-resistant organisms causing ventilator-associated pneumonia in a tertiary care hospital: A nine months’ prospective study. Ann Thoracic Med2007;2:52-7.
  3. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic 'blind' bronchoalveolar lavage fluid. Am Rev Respir Dis 1991;143:1121–29.
  4. Collee JG, Miles RS, Watt B. Tests for the identification of bacteria. In: Mackie & McCartney‟s Practical Medical Microbiology. 14th Eds. Collee JG, Fraser AG, Marmion BP, Simmons A. Churchill Livingstone, Elsevier imprint. 2006; pp 131-49.
  5. Clinical and Laboratory Standards Institute. M100-S23. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Third Informational Supplement. January 2013;32:pp 44-52,62-7,72-9.
  6. Gadani H, Vyas A, Kar AK. A study of ventilator-associated pneumonia: Incidence, outcome, risk factors and measures to be taken for prevention. Indian J Anaesth 2010;54:535-40.
  7. Gupta A, Agrawal A, Mehrotra S, Singh A, Malik S, Khanna A. Incidence, risk stratification, antibiogram of pathogens isolated and clinical outcome of ventilator associated pneumonia. Indian J Crit Care Med 2011;15:96-101.
  8. Rakshit P, Nagar VS, Deshpande AK. Incidence, clinical outcome and risk stratification of ventilator associated pneumonia: a prospective cohort study. Indian J Crit Care Med 2005;9:211-6.
  9. Alp E, Güven M, Yildiz O, Aygen B, Voss A, Doganay M. Incidence,  risk factors and mortality of nosocomial pneumonia in Intensive Care Units: A prospective study. Ann Clinical Microbiology and Antimicrobials 2004;3:17.
  10. Fernando LAC, Fernando VDM, Carmen SVB, Cristiane H, Marco ASB, Milton RJr, et al. Ventilator Associated Pneumonia: comparison between quantitative and qualitative cultures of tracheal aspirates. Crit Care 2004;8:R422-30.
  11. Arango VM, Torres AM, Ordenana IJ et al. Diagnostic value of quantitative cultures of endotracheal aspirate in ventilator-associated pneumonia: a multicentre study. Arch Bronconeumol 2003;39:394-9.
  12. Fabregas N, Ewig S, Torres A, El-Ebiary M, Ramirez J, Puig de la Bellacasa et al. Clinical diagnosis of ventilator associated pneumonia revisited, comparative validation using immediate post-mortem lung biopsies. Thorax 1999;54:867-73.
  13. Joseph NM, Sistla S, Dutta TK, Badhe AS, Rasitha D, Parija SC. Ventilator-associated pneumonia in a tertiary care hospital in India : role of multi-drug resistant pathogens. J Infect Dev Ctries 2010;4:218-25.
  14. Ibrahim EH, Ward S, Sherman RN, Kollef MH. A comparative analysis of patient with early-onset vs late-onset nosocomial pneumonia in the ICU setting. Chest 2000;117:1434-42.
  15. Thakuria B, Singh P, Agrawal S, Asthana V. Profile of infective microorganisms causing ventilator-associated pneumonia: A clinical study from resource limited intensive care unit. Journal of Anaesthesiology Clinical Pharmacology 2013;29:361-6.
  16. Goel N, Chaudhary U, Aggarwal R, Bala K. Antibiotic sensitivity pattern of gram negative bacilli isolated from the lower respiratory tract of ventilated patients in the intensive care unit. Indian J Crit Care Med. 2009;13:148–51.
  17. Saldanha Dominic RM, Prashanth HV, Shenoy S, Baliga S. A clinico-microbio-logical study of ventilator associated pneumonia in a tertiary care hospital. Int J Biol Med Res. 2012;3:1651-54.
  18. Combes A, Figliolini C, Trouillet JL, Kassis N, Wolff M, Gilbert C, et Incidence and outcome of polymicrobial ventilator-associated pneumonia. Chest 2002;121:1618-23.
  19. Mukhopadhyay C, Krishna S, Shenoy A, Prakashini K. Clinical, radiological and microbiological corroboration to assess the role of endotracheal aspirate in diagnosing ventilator-associated pneumonia in an intensive care unit of a tertiary care hospital, India. Int J Infect Control 2010; 6:1991-99.
  20. Rajasekhar T, Anuradha K, Suhasini T, Lakshmi V. The role of quantitative cultures of non-bronchogenic samples in VAP. Indian J Med Microbiology 2006;24:107-13.
  21. Dwivedi M, Mishra A, Azim A, Singh RK, Baronia AK, Prasad KN, et Ventilator-associated pneumonia caused by carbapenem-resistant enterobacteriaceae carrying multiple-beta-lactamase genes. Indian J Pathol Microbiol 2009;52:339-42.
  22. Modi P, Javadekar T, Javadekar B. Development of bacteremia in VAP patients at a tertiary care hospital, Gujarat-a prosp-ective study. National JMR 2011;1:23-6.
  23. Luna CM, Videla A, Mattera J, Vay C, Famiglietti A, Vujacich P et al. Blood cultures have limited value in predicting severity of illness and as a diagnostic tool in ventilator-associated pneumonia. Chest 1999;116.

Corresponding Author

Dr Arghadip Samaddar

Senior Resident, Department of Microbiology,

Lokmanya Tilak Municipal Medical College & General Hospital,

Sion, Mumbai- 400022, Maharashtra (India)

Tel: +919932560720, Email: This email address is being protected from spambots. You need JavaScript enabled to view it.